Pure Global
NCT06153862

Africa Ready Malaria Screening

University of Ghana·ClinicalTrials.gov·diagnostic testRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Malaria
Drug/Device/Intervention
Immuno analytical assay
Study type
Interventional
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
University of Ghana
Location
Dodowa, Ghana
Timeline & enrollment
Phase
N/A
Start date
Sep 23, 2022
End date
Sep 01, 2025
Enrollment
1640 participants
Primary outcome

MSP1-19 malaria antigen

Summary

This study aims to develop immuno-analytical assays for testing the titres of malaria
 antibodies in Ghanaian patients' and/or donors' sera using a recombinantly produced MSP119
 fusion protein and/or MSP119-derived synthetic peptides as antigens.

ICD-10 classifications
Unspecified malariaPlasmodium malariae malariaPlasmodium falciparum malariaOther parasitologically confirmed malariaPlasmodium ovale malaria
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06153862
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06153862 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Ghana and is currently Recruitment Completed. The study focuses on Malaria. Target enrollment is 1640 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.